MedTrace Logo

Enhancing Inpatient Psychotherapeutic Treatment With Online Self-help : Acceptance and Efficacy

NCT02196896 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 229

Last updated 2017-03-17

No results posted yet for this study

Summary

The purpose of this study is to determine the acceptance and efficacy of the online self-help program deprexis® for depressed patients in reducing the clinical symptoms of their depression. The patients of the experimental group use deprexis® for 90 days, the patients of the placebo group receive weekly online information about depression for 90 days as well. Both groups receive their treatment in addition to their regular inpatient psychosomatic treatment and as an aftercare intervention.The investigators hypothesize that the online self-help group achieves a greater reduction of depression compared to the control group.

Conditions

Interventions

OTHER

deprexis®

Online self-help program in addition to inpatient psychosomatic treatment for 90 days.

OTHER

Information

The patients receive online information about depression once a week for 90 days.

Sponsors & Collaborators

  • Rhön-Klinikum AG

    collaborator UNKNOWN

  • Johannes Gutenberg University Mainz

    lead OTHER

Principal Investigators

  • Manfred E Beutel, Prof. Dr. · University Medical Center, Department of Psychosomatic Medicine and Psychotherapy, Johannes Gutenberg University Mainz

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-06-30
Primary Completion
2016-11-30
Completion
2016-11-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02196896 on ClinicalTrials.gov